INVITRO AND INVIVO PRE-CLINICAL CHEMOTHERAPY STUDIES OF HUMAN NEURO-BLASTOMA
- 1 January 1980
- journal article
- research article
- Vol. 64 (8-9) , 975-979
Abstract
Two human neuroblastoma cell lines, LA-N-1 and SK-N-MC growing in vitro and as s.c. tumors in athymic nude mice, were evaluated for their sensitivity to cyclophosphamide, doxorubicin (adriamycin) and vincristine. In vitro, cyclophosphamide, following liver S-9 metabolic activation, and vincristine were significantly more cytotoxic to SK-N-MC than to LA-N-1 cells; doxorubicin was equally cytotoxic to both cell types. Treatment of nude mice bearing LA-N-1 and SK-N-MC tumors with cyclophosphamide and vincristine produced significant reduction (> 50%) in SK-N-MC tumor weights but not in LA-N-1 tumor weights. Doxorubicin failed to produce significant reduction in the weight of the LA-N-1 or the SK-N-MC tumor. These sensitivities were generally similar to the clinical response of the tumors to these same agents. Such an in vitro and in vivo system using these and other neuroblastoma cell lines may provide a preclinical model for evaluating the activity of chemotherapeutic agents against human neuroblastoma.This publication has 4 references indexed in Scilit:
- Isolation and characterization of a neuroblastoma cell line from peripheral blood in a patient with disseminated diseaseCancer, 1977
- MORPHOLOGY, GROWTH, CHROMOSOMAL PATTERN, AND FIBRINOLYTIC-ACTIVITY OF 2 NEW HUMAN NEUROBLASTOMA CELL LINES1977
- ADRENERGIC, CHOLINERGIC, AND INACTIVE HUMAN NEUROBLASTOMA CELL LINES WITH ACTION-POTENTIAL NA+ IONOPHORE1977
- ESTABLISHMENT AND CHARACTERIZATION OF HUMAN NEUROBLASTOMA CELL LINES1976